Back to Search
SHELDON LINN, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1821195926Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
MD036165E(PA)
Research & Publications (20)
[Novel approaches; improved diagnosis and therapy with DNA microarrays. I. Technology and data analysis].
PMID 12741167·Ned Tijdschr Geneeskd·2003
6-review
[Novel approaches; improved diagnostics and therapeutics with DNA microarrays. II. Applications].
PMID 12741168·Ned Tijdschr Geneeskd·2003
6-review
Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans.
PMID 14633610·Am J Pathol·2003
8-other
Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption.
PMID 11709083·Biochem Soc Trans·2001
6-review
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.
PMID 19514094·Psychooncology·2010
8-other
The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment.
PMID 19622588·Ann Oncol·2010
4-observational
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
PMID 19126254·Int J Technol Assess Health Care·2009
8-other
Burkitt lymphoma in children: the Israeli experience.
PMID 19648792·J Pediatr Hematol Oncol·2009
4-observational
Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
PMID 18311582·Breast Cancer Res Treat·2009
4-observational
Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry.
PMID 19589736·J Chromatogr B Analyt Technol Biomed Life Sci·2009
4-observational
Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
PMID 19353633·J Pathol·2009
8-other
Non-Hodgkin Lymphoma (NHL) linkage with residence near heavy roads--a case study from Haifa Bay, Israel.
PMID 19081284·Health Place·2009
8-other
Phosphorylation of the oestrogen receptor alpha at serine 305 and prediction of tamoxifen resistance in breast cancer.
PMID 18991335·J Pathol·2009
4-observational
Validation of 70-gene prognosis signature in node-negative breast cancer.
PMID 18819002·Breast Cancer Res Treat·2009
4-observational
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy.
PMID 19095215·Am J Surg·2009
4-observational
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
PMID 18777410·Acta Oncol·2009
4-observational
Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.
PMID 18708938·Am J Surg Pathol·2008
8-other
[Evaluation of ergonomic conditions of video display terminal operators in a general hospital].
PMID 18814515·Harefuah·2008
8-other
[The effect of hormone therapy on cognitive function in patients with breast cancer].
PMID 18389880·Ned Tijdschr Geneeskd·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 322 S 17TH ST
ALLENTOWN, PA 18104 - Phone
- (610) 434-4015
Quick Facts
- NPI
- 1821195926
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile